3 completed, 2 withdrawn. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Completed 3, Withdrawn 2 |
Follow End Stage Renal Disease: new trials by email Literature Review of End Stage Renal Disease trials Research Report on End Stage Renal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis Valine, EEA - End Stage Renal Disease | Early Phase 1 | Completed | The University of Texas Health Science Center at San Antonio | 28 | 2024-10-18 | 2026-08-26 |
| Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients 1.25mg bevacizumab, 2.50mg bevacizumab - End Stage Renal Disease, Hemodialysis Vascular Access Failure | Early Phase 1 | Withdrawn | Mayo Clinic | 2019-08-01 | 2026-06-24 | |
| A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients Treg - End Stage Renal Disease, Kidney Transplant | Early Phase 1 | Completed | Roberto Gedaly | 9 | 2019-03-15 | 2024-06-24 |
| Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease Rifaximin - End Stage Renal Disease | Early Phase 1 | Withdrawn | Jason Stubbs, MD | 2016-01-01 | 2019-02-28 | |
| Goal Directed Fluid Administration for Kidney Transplantation goal directed fluid therapy, Control Group - End Stage Renal Disease | Early Phase 1 | Completed | Medical University of South Carolina | 21 | 2012-08-01 | 2018-04-10 |
Kidney Failure, Chronic (5) · Arteriovenous Fistula (1) · Fatigue (1)
Chronic Disease (5) · Disease Attributes (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Renal Insufficiency (5) · Renal Insufficiency, Chronic (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Arteriovenous Malformations (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1)
Bevacizumab (1) · Control Groups (1) · Rifaximin (1) · Valine (1)
Jason Stubbs, MD (1) · Mayo Clinic (1) · Medical University of South Carolina (1) · Roberto Gedaly (1) · The University of Texas Health Science Center at San Antonio (1)
United States (3)
Jason Stubbs, MD (1) · Roberto Gedaly, MD (1) · Sanjay Misra, MD (1) · Scott T Reeves, MD (1) · Subrata Debnath, PhD (1) · William Hand, MD (1)
KL2TR002646 (1)